United BioSource, LLC: Clinical Trials

14 trials sponsored by United BioSource, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 active not recruiting, 2 terminated, 1 approved for marketing. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 31Completed 1

Follow United BioSource, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
Micronized DHACM 40 mg, Micronized DHACM 100 mg, Saline - Knee Osteoarthritis
Phase 2TerminatedMiMedx Group, Inc.432023-03-242024-01-17
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
LUPKYNIS - Lupus Nephritis
CompletedAurinia Pharmaceuticals Inc.2292022-04-052025-06-24
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Data Collection - Hereditary Transthyretin Amyloidosis With Polyneuropthy
Active not recruitingAkcea Therapeutics2022021-09-212026-07-29
A Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta
Data-collection - Neuroblastoma
Active not recruitingRECORDATI GROUP1252019-09-302026-10-26
An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
TerminatedAriad Pharmaceuticals32018-03-022024-04-04
Developing a COPD Case Finding Methodology for Primary Care
Chronic Obstructive Pulmonary Disease (COPD)
CompletedUniversity of Michigan3462013-02-012016-05-11
Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
Beclomethasone Dipropionate (BDP) Nasal Aerosol - Perennial Allergic Rhinitis (PAR)
CompletedTeva Branded Pharmaceutical Products R&D, Inc.8242012-07-012014-04-15
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
No treatment given - Diabetes, Diabetes Mellitus, Type 2
Enrolling by invitationNovo Nordisk A/S67502012-01-012023-06-13
JC-Virus (JCV) Antibody Program
Tysabri® (natalizumab) - Multiple Sclerosis
CompletedBiogen10962010-03-012016-10-05
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
LY2189265, Sitagliptin, Placebo solution - Diabetes Mellitus, Type 2
Phase 2 / Phase 3CompletedEli Lilly and Company12022008-08-012015-04-20
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
S-1 - Locally Advanced or Metastatic Pancreatic Cancer
Phase 2CompletedTaiho Oncology, Inc.282006-01-092024-09-19
Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer
S-1 - Advanced Non-Small Cell Lung Cancer
Phase 2CompletedTaiho Oncology, Inc.572005-02-012024-09-03
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
S-1 - Advanced Non-Small Cell Lung Cancer
Phase 2CompletedTaiho Oncology, Inc.602005-02-012024-09-03
AveXis Managed Access Program Cohort for Access to AVXS-101
AVXS-101 - Spinal Muscular Atrophy
Approved for marketingUnited BioSource, LLC2020-08-28

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Amyloidosis (1)  ·  Amyloidosis, Hereditary, Transthyretin-Related (1)  ·  Blast Crisis (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Medullary (1)  ·  Diabetes Mellitus (1)  ·  Leukemia (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid (1)  ·  Lupus Nephritis (1)  ·  Multiple Sclerosis (1)  ·  Muscular Atrophy, Spinal (1)  ·  Neoplasms (1)  ·  Neuroblastoma (1)

Interventions

S 1 (combination) (3)  ·  Data Collection (2)  ·  Beclomethasone (1)  ·  Metformin (1)  ·  Nasal Sprays (1)  ·  Natalizumab (1)  ·  Sitagliptin Phosphate (1)  ·  Sodium Chloride (1)  ·  Zolgensma (1)  ·  alpha-ketoisovalerate dehydrogenase phosphatase (1)  ·  dulaglutide (1)  ·  voclosporin (1)

Countries

United States (9)  ·  France (3)  ·  Germany (3)  ·  Spain (3)  ·  Italy (2)  ·  Poland (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Cyprus (1)  ·  Greece (1)  ·  India (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Puerto Rico (1)

Top investigators

Fabio Benedetti, MD (2)  ·  Annette Stemhagen, DrPH, FISPE (1)  ·  David Mannino, MD (1)  ·  Fernando J Martinez, MD, MS (1)  ·  Ignacio Alvarez (1)  ·  Mark Lepore, MD (1)  ·  Nancy K Leidy, PhD (1)  ·  Taiho Central (1)

Results publications

PMID 23294774, PMID 24762094, PMID 25912221, PMID 26691396, PMID 27161178, PMID 27783539, PMID 28414029, PMID 28755389, PMID 29942123, PMID 33179845, PMID 36894938

NIH funding

R01HL114055 (1)